Mario Polywka

Mario is a Member of the Supervisory Board of drug discovery and development company, Evotec. He has extensive experience as a Non-Executive Director within the healthcare industry, having also held positions at Forge Therapeutics and Pharminox. Prior to that, he served as Chief Operating Officer at Evotec and was a Founding Chemist of Oxford Asymmetry International. He received a doctorate in mechanistic organometallic chemistry from the University of Oxford before continuing there with post-doctoral studies on aspects of the biosynthesis of penicillins.